Ebola Antigen Rapid Test Kit Manufacturers, Exporters & Wholesale Suppliers
Trusted Ebola Rapid Test Kit Manufacturer & Global Supplier for Hospitals, Laboratories, Distributors & Public Health Programs
Jal Medical’s iCARE Ebola Antigen Rapid Test Kit is a professional-use lateral flow immunoassay for the qualitative detection of Ebola virus antigens in human whole blood, serum, or plasma – delivering results in 15–20 minutes. As an established Ebola test kit manufacturer, Jal Medical supplies this Ebola diagnostic kit to hospitals, laboratories, government health programs, NGOs, and medical distributors across Africa, the Middle East, and beyond, with dependable bulk, OEM, and private label supply programs built for international procurement.
Why Global Buyers Choose Jal Medical’s Ebola Test Kit
Sourcing a reliable Ebola diagnostic kit supplier for hospital networks, outbreak-response teams, or national screening programs demands consistent quality, fast turnaround, and dependable supply. Jal Medical delivers on all three, backed by rigorous clinical and analytical validation:
- Proven precision –Correctly identified antigen levels from negative through strong positive across all replicate testing, supporting consistent, repeatable performance.
- Validated clinical accuracy –Evaluated against reference RT-PCR testing with 85.00% sensitivity and 99.66% specificity, giving clinical teams a fast antigen-based screening option ahead of confirmatory testing.
- Multi-specimen compatibility – Works with whole blood, serum, and plasma specimens, offering flexibility for hospital labs and field-based outbreak response teams alike.
- Rapid, field-ready results –Delivers a visual result in 15–20 minutes with no laboratory instrumentation required – critical for point-of-care Ebola testing in remote or resource-limited settings.
- Broad specificity profile –No cross-reactivity observed against Yellow Fever, Rift Valley Fever, Chikungunya, Influenza A/B, Rotavirus, Adenovirus, RSV, Enterovirus, Salmonella, Salmonella typhi, and both major malaria species (P. falciparum, P. vivax) and Dengue – reducing false positives in co-endemic regions.
- No high-dose hook effect –No hook effect detected even at concentrations up to 10,000 times the established limit of detection, ensuring reliable results even in high-viral-load specimens.
- Flexible kit sizing –Available in 25 Tests/Kit and 40 Tests/Kit formats, supporting both routine hospital use and large-volume outbreak-response procurement.
- Export-ready shelf life –24-month shelf life, stable at 2–40°C, suited for long-distance export and storage across varied climates without cold-chain dependency.
| Attribute | Detail |
|---|---|
| Product | iCARE Ebola Antigen Rapid Test |
| Format | Lateral flow immunochromatographic immunoassay (IVD) |
| Analyte | Ebola virus antigen (qualitative detection) |
| Sample Types | Whole Blood / Serum / Plasma |
| Result Time | 15–20 minutes |
| Kit Sizes | 25 Tests/Kit, 40 Tests/Kit |
| Shelf Life | 24 months from date of manufacture |
| Storage | 2–40°C |
| End Users | Hospitals, clinical laboratories, outbreak-response teams, NGOs, government health programs |
| Supply Options | Bulk / Wholesale / OEM / Private Label |
Built for Institutional, Government & Outbreak-Response Procurement
Whether you are a hospital diagnostic buyer, an Ebola test kit distributor serving multiple markets, or a government health ministry preparing for outbreak response, Jal Medical structures supply to match your scale and urgency:
- Bulk & Wholesale Orders –Competitive per-unit pricing on large-volume purchases, with flexible minimum order quantities for hospital groups, laboratory chains, and public health procurement – including wholesale Ebola test kit and bulk Ebola test kit orders.
- OEM & Private Label Manufacturing –Brand the Ebola Antigen Rapid Test under your own label for distribution in your target markets, with full OEM Ebola rapid test kit and private label Ebola test kit programs available.
- Distributor & Dealer Partnerships –Exclusive and non-exclusive territory agreements for importers and medical distributors across Nigeria, Uganda, Kenya, Ghana, Tanzania, South Africa, the UAE, Saudi Arabia, and other regions.
- Export-Ready Documentation –Product dossiers, certificates of analysis, and regulatory documentation prepared to support import registration and tender submissions.
- Reliable Logistics –Packaging and cold-chain-independent storage (2–40°C) designed for international freight into hot and humid climates without specialized transport.
- Outbreak-Response Readiness –Priority production and expedited shipment options available for outbreak-response and emergency stockpiling needs.
How the Ebola Antigen Rapid Test Works
The Ebola Antigen Rapid Test is a qualitative, membrane-based immunochromatographic test that detects Ebola virus antigen directly in a patient specimen. As the specimen migrates across the test strip, it mobilizes a gold-labeled anti-Ebola conjugate; if Ebola virus antigen is present, it binds to the conjugate and is captured at the test line (T), producing a visible colored line. A control line (C) appears on every valid run, confirming correct test function and adequate specimen volume – giving procurement and clinical teams confidence in consistent, quality-controlled results across every batch and every kit lot.
Any visible test line, however faint, within the observation window indicates a positive result. This makes the Ebola lateral flow test a straightforward visual read requiring no laboratory instrumentation – ideal for point-of-care Ebola testing in hospital wards, field clinics, and outbreak-response units.
Result Interpretation
| Result | Line Pattern |
|---|---|
| Positive | Control (C) line + Test (T) line – any visible T line is positive |
| Negative | Control (C) line only; no T line |
| Invalid | No control line appears – repeat with a new device |
Clinical & Analytical Performance
The Ebola Antigen Rapid Test was evaluated against a reference RT-PCR assay using clinical specimens, and further characterized for precision, limit of detection, hook effect, cross-reactivity, and interference:
| Parameter | Result |
|---|---|
| Sensitivity (vs. RT-PCR) | 85.00% (95% CI: 77.53%–90.30%) |
| Specificity (vs. RT-PCR) | 99.66% (95% CI: 98.14%–99.94%) |
| Overall Accuracy | 95.47% (95% CI: 93.04%–97.09%) |
| Limit of Detection (LoD) | 1.7 × 10⁶ TCID₅₀/mL (Ebola Inactivated Virus, whole blood) |
| Hook Effect | None observed up to 10,000× the established LoD |
| Precision | Negative, weak, medium, and strong positive specimens correctly identified across all replicate runs |
No cross-reactivity was observed against Yellow Fever, Rift Valley Fever, Chikungunya virus, Influenza A, Influenza B, Rotavirus, Adenovirus, RSV, Enterovirus, Salmonella, Salmonella typhi, Plasmodium falciparum, Plasmodium vivax, or Dengue. Test performance was also unaffected by bilirubin, hemoglobin, HAMA, and protein at the concentrations tested – supporting reliable use across diverse clinical presentations and co-endemic disease regions.
Supporting Outbreak Preparedness & Public Health Response
Ebola virus disease (EVD) is an acute, often fatal illness that can be difficult to distinguish clinically from malaria, typhoid fever, and meningitis. Because early identification is critical to outbreak containment and patient management, health systems increasingly rely on rapid antigen-capture testing to triage suspected cases ahead of confirmatory RT-PCR. Jal Medical’s Ebola rapid test kit supports hospitals, NGOs, and government health programs across outbreak-prone regions – including Nigeria, Uganda, Kenya, Ghana, Tanzania, and South Africa – with dependable supply for both routine surveillance and emergency response stockpiling.
Kit Contents
- Test device –individually foil-pouched with desiccant
- Sample diluent
- Dropper (specimen delivery)
- Package insert with full test procedure and result interpretation guidance
Available in 25 Tests/Kit and 40 Tests/Kit configurations to suit hospital, laboratory, and outbreak-response ordering volumes.
About Jal Medical
Jal Medical, through its iCARE Advanced diagnostics range, manufactures and exports a portfolio of rapid immunoassay and IVD test kits – including antigen, antibody, and infectious disease screening solutions – to hospitals, laboratories, distributors, and government health programs worldwide. Our manufacturing and quality systems are built to support the demands of international Ebola test kit exporters, dealers, and hospital procurement teams, combining the responsiveness of a dedicated partner with the scale of a global diagnostic kit supplier.
Frequently Asked Questions
What is an Ebola Antigen Rapid Test?
It is a rapid, lateral flow immunochromatographic test that qualitatively detects Ebola virus antigen in human whole blood, serum, or plasma, used as an aid in diagnosing Ebola virus infection.
How does an Ebola Rapid Test work?
The specimen migrates across a test strip and mobilizes a gold-labeled anti-Ebola conjugate. If Ebola virus antigen is present, it is captured at the test line, producing a visible colored line, while a separate control line confirms the test ran correctly.
What sample is required for an Ebola Test?
The test accepts human whole blood (fingerstick or venipuncture), serum, or plasma specimens.
How accurate is an Ebola Antigen Test?
When evaluated against reference RT-PCR testing, the iCARE Ebola Antigen Rapid Test demonstrated 85.00% sensitivity, 99.66% specificity, and 95.47% overall accuracy.
What is the difference between an Ebola Antigen Test and RT-PCR?
The antigen rapid test is a visual, point-of-care immunoassay that delivers results in 15–20 minutes without laboratory equipment, while RT-PCR is a molecular laboratory method that detects viral genetic material and is typically used to confirm results from rapid antigen testing.
How long does an Ebola Rapid Test take?
Results are read at 15–20 minutes. Results should not be interpreted after 20 minutes.
Can Ebola be detected by a Rapid Test?
Yes. The Ebola Antigen Rapid Test can detect Ebola virus antigen directly from a patient specimen as a rapid screening aid, though positive and negative results should be confirmed with additional clinical and laboratory methods such as RT-PCR.
What is a Point-of-Care Ebola Test?
A point-of-care Ebola test is a rapid diagnostic kit that can be performed outside a central laboratory - in a hospital ward, clinic, or field setting - delivering a visual result without specialized instrumentation.
Who should use an Ebola Rapid Test?
This test is intended for use by trained healthcare professionals in hospitals, clinical laboratories, and outbreak-response settings, in patients presenting with symptoms suggestive of Ebola virus infection.
How is Ebola Virus Disease diagnosed?
EVD can be diagnosed using antibody-capture ELISA, antigen-capture detection tests such as this rapid test, serum neutralization testing, RT-PCR, electron microscopy, or virus isolation by cell culture, generally used in combination with clinical assessment.
When should an Ebola Antigen Test be performed?
Testing is typically recommended when a patient presents with symptoms consistent with Ebola virus infection, such as sudden fever, fatigue, muscle pain, or symptoms of bleeding, particularly with a history of exposure in an outbreak-affected region.
What is the intended use of an Ebola Rapid Test Kit?
It is intended as a rapid, qualitative screening aid for the detection of Ebola virus antigen in whole blood, serum, or plasma, to support - not replace - clinical diagnosis and confirmatory laboratory testing.
Does Jal Medical supply Ebola test kits in bulk for hospitals and government tenders?
Yes. Jal Medical supplies the Ebola Antigen Rapid Test Kit in bulk volumes for hospitals, laboratory networks, NGOs, and government procurement programs, with pricing scaled to order size.
Can Jal Medical provide documentation for product registration in my country?
Yes. Jal Medical provides product dossiers, certificates of analysis, and supporting regulatory documentation to assist distributors with local import and registration requirements.